Average, who was born Brock David Tebbutt in 1957 in Victoria, was diagnosed with HIV at 27 years old, at a time when the diagnosis was widely considered a death sentence.

Tremelimumab is under clinical development by AstraZeneca and currently in Phase II for Salivary Gland Cancer.

Through Dec. 20, the FDA approved 50 brand new medicines, defined as proteins, small molecules, or other chemicals this year.

South Africa spends over R30 billion annually on its HIV-Aids programs, which includes the costs of its extensive ART ...

In a major step forward in the fight against HIV/AIDS, the US Food and Drug Administration (FDA) has approved Lenacapavir, an ...

Matthew Kavanagh, the director of Georgetown University's Centre for Global Health Policy & Politics and an advisor to the United Nations explains on the progress and challenges in the ...

HIV/AIDS cases and deaths have gone up dramatically in the Philippines in the last decade, even though there are drugs to ...

Therefore, seeing his neighbour fraternising regularly with Niger’s former coloniser must have sent chills down Tchiani’s ...

Despite the seeming perception of a diminishing spread of HIV/AIDS with the advent of new viruses, the Niger Delta ...

Despite the seeming perception of a diminishing spread of HIV/AIDS, NDDC has warned that the scourge remains dangerous to ...

So my fondest hope for 2025 and beyond, is that we CAN work on being understanding, kind, considerate and move forward to a ...

Pakistan is witnessing a sharp rise in HIV cases, with an average of 1,079 new infections reported each month in 2024.